MXI1, a member of the Mad family proteins known to antagonize c-MYC-dependent transcription, has a potential oncogenic role in RCC, as MXI1 knockdown impaired kidney cancer xenograft formation in nude mice107. Here, MYC is linked to renal cell carcinoma.